Minoru Kitago

Person

People

Patents Applicationslast 30 patents

Information Patent Application
USE OF RUNX3 AND MIR-532-5P AS CANCER MARKERS AND THERAPEUTIC TARGETS
- Publication number 20120148561
- Publication date Jun 14, 2012
- JOHN WAYNE CANCER INSTITUTE
- Dave S.B. Hoon
- G01 - MEASURING TESTING
Information Patent Application
USE OF RUNX3 AND MIR-532-5P AS CANCER MARKERS AND THERAPEUTIC TARGETS
- Publication number 20110158975
- Publication date Jun 30, 2011
- Dave S.B. Hoon
- G01 - MEASURING TESTING
Information Patent Application
USE OF RUNX3 AND MIR-532-5P AS CANCER MARKERS AND THERAPEUTIC TARGETS
- Publication number 20110159509
- Publication date Jun 30, 2011
- Dave S.B. Hoon
- G01 - MEASURING TESTING
Information Patent Application
UTILITY OF HIGH MOLECULAR WEIGHT MELANOMA ASSOCIATED ANTIGEN IN DIA...
- Publication number 20110124004
- Publication date May 26, 2011
- Dave S.B. Hoon
- G01 - MEASURING TESTING
Information Patent Application
UTILITY OF HIGH MOLECULAR WEIGHT MELANOMA ASSOCIATED ANTIGEN IN DIA...
- Publication number 20110124007
- Publication date May 26, 2011
- Dave S.B. Hoon
- G01 - MEASURING TESTING
Information Patent Application
USE OF RUNX3 AND MIR-532-5P AS CANCER MARKERS AND THERAPEUTIC TARGETS
- Publication number 20100227319
- Publication date Sep 9, 2010
- John Wayne Cancer Institute
- Dave S.B. Hoon
- G01 - MEASURING TESTING
Information Patent Application
UTILITY OF HIGH MOLECULAR WEIGHT MELANOMA ASSOCIATED ANTIGEN IN DIA...
- Publication number 20080076727
- Publication date Mar 27, 2008
- John Wayne Cancer Institute
- Dave S.B. Hoon
- G01 - MEASURING TESTING

Minoru Kitago

Person

Patents Applicationslast 30 patents

USE OF RUNX3 AND MIR-532-5P AS CANCER MARKERS AND THERAPEUTIC TARGETS

USE OF RUNX3 AND MIR-532-5P AS CANCER MARKERS AND THERAPEUTIC TARGETS

USE OF RUNX3 AND MIR-532-5P AS CANCER MARKERS AND THERAPEUTIC TARGETS

UTILITY OF HIGH MOLECULAR WEIGHT MELANOMA ASSOCIATED ANTIGEN IN DIA...

UTILITY OF HIGH MOLECULAR WEIGHT MELANOMA ASSOCIATED ANTIGEN IN DIA...

USE OF RUNX3 AND MIR-532-5P AS CANCER MARKERS AND THERAPEUTIC TARGETS

UTILITY OF HIGH MOLECULAR WEIGHT MELANOMA ASSOCIATED ANTIGEN IN DIA...